Sterling Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$20.8K Buy
5,248
+4,466
+571% +$18.6K ﹤0.01% 2173
2026
Q2
$3.29K Sell
782
-571
-42% -$2.2K ﹤0.01% 2823
2026
Q1
$4.75K Sell
1,353
-563
-29% -$2.31K ﹤0.01% 2756
2025
Q4
$6.46K Buy
1,916
+675
+54% +$1.75K ﹤0.01% 2802
2025
Q3
$1.63K Buy
1,241
+539
+77% +$558 ﹤0.01% 3010
2025
Q2
$503 Sell
702
-1,027
-59% -$806 ﹤0.01% 3153
2025
Q1
$2.54K Sell
1,729
-1,314
-43% -$3.13K ﹤0.01% 2497
2024
Q4
$13.5K Buy
3,043
+2,670
+716% +$10.8K ﹤0.01% 2021
2024
Q3
$1.54K Buy
+373
New +$2K ﹤0.01% 2317

Other funds holding IRWD

Sterling Capital Management's IRWD Position: Q3 2026 in Review

Sterling Capital Management increased its Ironwood Pharmaceuticals (IRWD) stake by 571% in Q3 2026, buying an estimated $18.6K and bringing the position to 5,248 shares worth $20.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2173.

Sterling Capital Management first reported a position in IRWD in Q3 2024 and has held it in 9 quarters since. 232 funds tracked by Wall St. Rank hold IRWD as of Q3 2026.

  • Sterling Capital Management held 5,248 shares of Ironwood Pharmaceuticals worth $20.8K as of Q3 2026.
  • Sterling Capital Management bought 4,466 Ironwood Pharmaceuticals shares in Q3 2026, an estimated $18.6K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Sterling Capital Management's portfolio in Q3 2026, its #2173 holding.
  • Sterling Capital Management first reported a position in Ironwood Pharmaceuticals in Q3 2024 and has held it in 9 quarters since.
  • 232 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2026.

Based on Sterling Capital Management's 13F filing for Q3 2026, filed 22 Oct 2026.